How many insider trades does FilingIQ track for VVOS?

FilingIQ tracks 20 Form 4 insider transactions for VVOS (Vivos Therapeutics, Inc.), covering filings from Dec 11, 2020 onwards. 5 of those were filed in the last 90 days.

Are VVOS insiders net buyers or net sellers?

Across the full Form 4 history for VVOS, 20 transactions (100%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VVOS insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VVOS in?

Vivos Therapeutics, Inc. (VVOS) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $15.07M.

VVOS insider trading

NasdaqCM Healthcare

Vivos Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

100% / 0%

Market cap

$15.07M

About Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Company website: www.vivos.com

VVOS insider activity at a glance

FilingIQ has scored 20 insider transactions for VVOS since Dec 11, 2020. The most recent filing in our index is dated Mar 31, 2026.

Across the full history, 20 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VVOS insider trades is 63.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VVOS trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for VVOS?: FilingIQ tracks 20 Form 4 insider transactions for VVOS (Vivos Therapeutics, Inc.), covering filings from Dec 11, 2020 onwards. 5 of those were filed in the last 90 days.
Are VVOS insiders net buyers or net sellers?: Across the full Form 4 history for VVOS, 20 transactions (100%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VVOS insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VVOS in?: Vivos Therapeutics, Inc. (VVOS) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $15.07M.

Methodology & sources

Every VVOS insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.